Low-loss Waveguides for THz Guidance and Devices

The terahertz (THz) region occupies a large portion of the electromagnetic spectrum, located between the microwave and optical frequencies and normally is defined as the band ranging from 0.1 to 10 THz. In recent years, this intermediate THz radiation band has attracted considerable interest, because it offers significant scientific and technological potential for applications in many fields, such as sensing [1], imaging [2] and spectroscopy [3]. However, waveguiding in this intermediate spectral region is a major challenge and strong dielectric and conductive losses in the terahertz frequency range have been a major problem for waveguiding. The conventional guiding structures exemplified by microstrips, coplanar striplines and coplanar waveguides [4] are highly lossy and dispersive. However, so far the most promising dielectric waveguides have been the use of photonic crystal fibers at terahertz frequencies [5, 6] and metal coated guides [7] at terahertz frequencies. In this paper, various types of practical dielectric and metal coated waveguides are evaluated and design optimization of Quantum Cascade Lasers, MMI-based power splitters and narrow-band filters are presented, by using full-vectorial finite element method [8]. © (2013) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only

Multimode Interference 3 dB Splitters in Hollow Core Metallic Waveguides for Low-Loss THz Wave Transmission

A multimode interference half-power splitter on hollow core polysterene-coated metallic waveguide is demonstrated in this study. The modal properties, propagation length, optical field evolution, and dispersion of the aforementioned device have been investigated using the full vectorial finite-element-based modal analysis and beam propagation method, as well as the finite-difference time-domain approach

Managing Multiple Business Models: The Role Of Interdependencies

How can a firm manage multiple and interdependent business models in the same industry? The literature has identified several possible strategies to do this, but we still do not know under what circumstances one strategy may be better than others. Our paper identifies (substitute and complementary) interdependencies among business models as a key contingency and demonstrates through simulation modelling that the number, type and magnitude of these interdependencies, as well as their visibility and the pre-specification of strategic choices, determine which organizational structure is optimal in managing multiple business models

Short-Term Evaluation of Cellular Fate in an Ovine Bone Formation Model.

The ovine critical-sized defect model provides a robust preclinical model for testing tissue-engineered constructs for use in the treatment of non-union bone fractures and severe trauma. A critical question in cell-based therapies is understanding the optimal therapeutic cell dose. Key to defining the dose and ensuring successful outcomes is understanding the fate of implanted cells, e.g., viability, bio-distribution and exogenous infiltration post-implantation. This study evaluates such parameters in an ovine critical-sized defect model 2 and 7 days post-implantation. The fate of cell dose and behaviour post-implantation when combined with nanomedicine approaches for multi-model tracking and remote control using external magnetic fields is also addressed. Autologous STRO-4 selected mesenchymal stromal cells (MSCs) were labelled with a fluorescent lipophilic dye (CM-Dil), functionalised magnetic nanoparticles (MNPs) and delivered to the site within a naturally derived bone extracellular matrix (ECM) gel. Encapsulated cells were implanted within a critical-sized defect in an ovine medial femoral condyle and exposed to dynamic gradients of external magnetic fields for 1 h per day. Sheep were sacrificed at 2 and 7 days post-initial surgery where ECM was harvested. STRO-4-positive (STRO-4+) stromal cells expressed osteocalcin and survived within the harvested gels at day 2 and day 7 with a 50% loss at day 2 and a further 45% loss at 7 days. CD45-positive leucocytes were also observed in addition to endogenous stromal cells. No elevation in serum C-reactive protein (CRP) or non-haem iron levels was observed following implantation in groups containing MNPs with or without magnetic field gradients. The current study demonstrates how numbers of therapeutic cells reduce substantially after implantation in the repair site. Cell death is accompanied by enhanced leucocyte invasion, but not by inflammatory blood marker levels. Crucially, a proportion of implanted STRO-4+ stromal cells expressed osteocalcin, which is indicative of osteogenic differentiation. Furthermore, MNP labelling did not alter cell number or result in a further deleterious impact on stromal cells following implantation

Therapeutic benefit for late, but not early, passage mesenchymal stem cells on pain behaviour in an animal model of osteoarthritis

Background: Mesenchymal stem cells (MSCs) have a therapeutic potential for the treatment of osteoarthritic (OA) joint pathology and pain. The aims of this study were to determine the influence of a passage number on the effects of MSCs on pain behaviour and cartilage and bone features in a rodent model of OA. Methods: Rats underwent either medial meniscal transection (MNX) or sham surgery under anaesthesia. Rats received intra-articular injection of either 1.5×106 late passage MSCs labelled with 10 μg/ml SiMAG, 1.5×106 late passage mesenchymal stem cells, the steroid Kenalog (200 μg/20 μL), 1.5×106 early passage MSCs, or serum-free media (SFM). Sham-operated rats received intra-articular injection of SFM. Pain behaviour was quantified until day 42 postmodel induction. Magnetic resonance imaging (MRI) was used to localise the labelled cells within the knee joint. Results: Late passage MSCs and Kenalog attenuated established pain behaviour in MNX rats, but did not alter MNX-induced joint pathology at the end of the study period. Early passage MSCs exacerbated MNX-induced pain behaviour for up to one week postinjection and did not alter joint pathology. Conclusion: Our data demonstrate for the first time the role of a passage number in influencing the therapeutic effects of MSCs in a model of OA pain

Thirty Years After Michael E. Porter: What Do We Know About Business Exit?

Although a business exit is an important corporate change initiative, the buyer’s side seems to be more appealing to management researchers than the seller’s because acquisitions imply growth, i.e., success. Yet from an optimistic viewpoint, business exit can effectively create value for the selling company. In this paper we attempt to bring the relevance of the seller’s side back into our consciousness by asking: What do we know about business exit? We start our exploration with Porter (1976), focusing on literature that investigates the antecedents of, barriers to, and outcomes of business exit. We also include studies from related fields such as finance and economics.1 Through this research we determine three clusters of findings: factors promoting business exit, exit barriers, and exit outcomes. Overall, it is the intention of this paper to highlight the importance of business exit for research and practice. Knowing what we know about business exits and their high financial value we should bear in mind that exit need not mean failure but a new beginning for a corporation

Target company cross-border effects in acquisitions into the UK

We analyse the abnormal returns to target shareholders in crossborder and domestic acquisitions of UK companies. The crossborder effect during the bid month is small (0.84%), although crossborder targets gain significantly more than domestic targets during the months surrounding the bid. We find no evidence for the level of abnormal returns in crossborder acquisitions to be associated with market access or exchange rate effects, and only limited support for an international diversification effect. However, the crossborder effect appears to be associated with significant payment effects, and there is no significant residual crossborder effect once various bid characteristics are controlled for

Operational optimisation of a non-recuperative 1-kWe organic Rankine cycle engine prototype

Several heat-to-power conversion technologies are being proposed as suitable for waste-heat recovery (WHR) applications, including thermoelectric generators, hot-air (e.g., Ericsson or Stirling) engines and vapour-cycle engines such as steam or organic Rankine cycle (ORC) power systems. The latter technology has demonstrated the highest efficiencies at small and intermediate scales and low to medium heat-source temperatures and is considered a suitable option for WHR in relevant applications. However, ORC systems experience variations in performance at part-load or off-design conditions, which need to be predicted accurately by empirical or physics-based models if one is to assess accurately the techno-economic potential of such ORC-WHR solutions. This paper presents results from an experimental investigation of the part-load performance of a 1-kWe ORC engine, operated with R245fa as a working fluid, with the aim of producing high-fidelity steady-state and transient data relating to the operational performance of this system. The experimental apparatus is composed of a rotary-vane pump, brazed-plate evaporator and condenser units and a scroll expander magnetically coupled to a generator with an adjustable resistive load. An electric heater is used to provide a hot oil-stream to the evaporator, supplied at three different temperatures in the current study: 100, 120 and 140 ∘ C. The optimal operating conditions, that is, pump speed and expander load, are determined at various heat-source conditions, thus resulting in a total of 124 steady-state data points used to analyse the part-load performance of the engine. A maximum thermal efficiency of 4.2 ± 0.1% is reported for a heat-source temperature of 120 ∘ C, while a maximum net power output of 508 ± 2 W is obtained for a heat-source temperature at 140 ∘ C. For a 100- ∘ C heat source, a maximum exergy efficiency of 18.7 ± 0.3% is achieved. A detailed exergy analysis allows us to quantify the contribution of each component to the overall exergy destruction. The share of the evaporator, condenser and expander components are all significant for the three heat-source conditions, while the exergy destroyed in the pump is negligible by comparison (below 4%). The data can be used for the development and validation of advanced models capable of steady-state part-load and off-design performance predictions, as well as predictions of the transient/dynamic operation of ORC systems.</jats:p